Advertisement
UK markets close in 5 hours 9 minutes

  • FTSE 100

    8,093.20
    +52.82 (+0.66%)
     

  • FTSE 250

    19,723.83
    +4.46 (+0.02%)
     

  • AIM

    755.43
    +0.74 (+0.10%)
     

  • GBP/EUR

    1.1669
    +0.0024 (+0.21%)
     

  • GBP/USD

    1.2521
    +0.0058 (+0.47%)
     

  • Bitcoin GBP

    50,892.64
    -2,122.73 (-4.00%)
     

  • CMC Crypto 200

    1,360.43
    -22.15 (-1.60%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    82.75
    -0.06 (-0.07%)
     

  • GOLD FUTURES

    2,337.60
    -0.80 (-0.03%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,984.62
    -104.08 (-0.58%)
     

  • CAC 40

    8,042.91
    -48.95 (-0.60%)
     
Stock:

Trending tickers

Microsoft, Google, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Bayer considering stopping sales of glyphosate to private users: newspaper

Reuters
·1-min read
A man uses a Monsanto's Roundup weedkiller spray containing glyphosate in a garden in Bordeaux

BERLIN (Reuters) - Bayer <BAYGN.DE> is considering stopping sales of the weedkiller glyphosate to private users who apply it in their gardens, German newspaper Handelsblatt reported on Thursday, citing financial and corporate sources.

The business daily said the move was part of ongoing talks with tens of thousands of plaintiffs in the United States about an out-of-court settlement. The plaintiffs blame Bayer's glyphosate-based weedkillers for their cancer.

Bayer was not immediately available for comment.

Court-appointed mediator Ken Feinberg, who leads the settlement discussions, has put the number of Roundup cancer claimants at more than 75,000 while Bayer has said the claims it has been served with in court were below 50,000.

(Reporting by Michelle Martin in Berlin and Sabine Wollrab in Frankfurt; Editing by Riham Alkousaa)